[Molecular targeting therapy by anti-VLA-4 monoclonal antibodies for AML].
Niitsu
Yoshiro
Y
Matsunaga
Takuya
T
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D004359:Drug Therapy, Combination; D005353:Fibronectins / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D019254:Genes, bcl-2; D006801:Humans; D039041:Integrin alpha4beta1 / Q000235:genetics / Q000276:immunology* / Q000502:physiology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D018365:Neoplasm, Residual / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D005353:Fibronectins; D039041:Integrin alpha4beta1